In addition, GPER (GPR30)has been also evidenced in neoplastic tissues from breast, endometrial and ovary cancers [12-14] as well as in breast [15-17], endometrial [18,19] ovarian [20] and thyroid carcinoma cells lines [21]. This evidence concerns the gene GPER1 and ovarian cancer.